David Kang, PhD

Director, Drug Delivery and Innovation
Halozyme Therapeutics

David Kang is a subject matter expert on recombinant human hyaluronidase facilitated rapid, large volume subcutaneous drug delivery and its application to biologics and ADCs.

Poster(s):

• Recombinant Human Hyaluronidase Improves PK of Subcutaneous ADC: Comparative Minipig Evaluation